|Bid||4.9400 x 1100|
|Ask||5.1700 x 2200|
|Day's Range||4.8200 - 5.2200|
|52 Week Range||4.6100 - 23.4900|
|Beta (5Y Monthly)||1.11|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 09, 2021 - Aug 13, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||23.33|
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of 22.22% and -57.99%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results and Provide a Corporate UpdateWOBURN, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial and operational results for the three and nine months ended September 30, 2021. “During the third quarter we continued to execute against our strategic objectives for 2021," said Oliver Peoples, Ph.D., Chief Executive Officer of